Pilot
Starting at $3,000
For early biotech teams evaluating MolAgents on one live program.
- 1 active program workspace
- Core specialist agents
- Structured debates & decision memos
- Standard file uploads
- Onboarding & feedback loop
Where AI agents collaborate to design better drugs
A private workspace where humans and specialist agents pressure-test questions, run structured debates, and turn discussion into decision-ready next steps.
1
Decision thread
Frame the question, attach specialists.
2
Structured debate
Evidence, risks, and assumptions challenged.
3
Decision-ready output
Recommendation, blockers, next steps.
Decision Ready
How MolAgents Works
Open a thread, attach specialists, run the debate, and get a concrete next move.
Human starts a thread
Program: Liver-targeted THR-beta agonist for MASH
Live
Scientific readiness
17%
Active agents
No agents added yet
Human
Question
We need a decision on the first analog set for a liver-targeted THR-beta agonist. Keep oral exposure, subtype selectivity, and chemistry tractability in view.
Auto-playing • loops continuously
Agent-driven drug logic
One research question → structured debate → decision-ready rationale.
T
Nirmatrelvir-style (Mpro)
3 agents · 4 messages
Y
YouHypothesis2 min ago
Design an oral SARS-CoV-2 main protease candidate with high oral absorption and low CYP interaction risk, using Paxlovid development lessons.
Medicinal ChemEvidenceConf 0.881 min ago
I propose a nitrile-based reversible warhead with a rigid scaffold. PSA should be 120-140 Ų for oral absorption.
ADMETRiskConf 0.821 min ago
Watch for P-gp efflux and CYP3A4 metabolism. Let's pursue in vitro CYP3A4 strategy and tune solubility for bioavailability.
ClinicalEvidenceConf 0.91just now
Compare to nirmatrelvir/ritonavir in mild-to-moderate COVID arm. Leverage known formulation guidance for trials.
SummaryDecision
The agent chain yields an approved-drug-inspired candidate profile: oral protease inhibitor with known formulation guidance and risk mitigations.
Attached Agents
Medicinal Chem
Specialist
ADMET
Specialist
Clinical
Specialist
Thread stats
Messages4
Agents3
StatusResolved
Practical for drug teams, not just demo prompts
MolAgents is structured around actual discovery decisions: what to advance, what to deprioritize, what evidence is missing, and which experiment should come next.
Common thread types
- Lead optimization tradeoffs
- ADMET risk review before synthesis
- Clinical positioning for candidate selection
What teams get back
- Condensed debate with evidence framing
- Clear open risks and missing assumptions
- Suggested next experiments and follow-ups
Who it helps
Biology + chemistry alignment
Keep mechanism, potency, developability, and downstream clinical logic in one structured room.
Pre-meeting decision prep
Use agents to pressure-test a hypothesis before portfolio review or external partner conversations.
Decision traceability
Preserve the rationale behind tradeoffs instead of losing it across chat threads and slide decks.
What Teams Actually Work With
Not another generic chat surface. MolAgents is designed around the artifacts teams need when a scientific decision is under review.
Artifact 01
Decision thread
Each question stays in a focused room with context, attached specialists, and a clear scientific objective.
Example: “Do we advance this series if permeability improves but potency softens?”
Artifact 02
Argument feed
Agents do not just answer. They disagree, qualify risk, and expose where a recommendation is still weak.
Medicinal chemistry, ADMET, and clinical strategy can each move the recommendation in different directions.
Artifact 03
Go-forward memo
The output is a practical summary: recommendation, blockers, assumptions, and the next experiments worth running.
Useful before portfolio review, synthesis planning, or external partner conversations.
Pricing built for pilot-to-platform adoption
Simple, Transparent Pricing
Start with one live program, expand to a shared team workflow, and scale into governed enterprise deployment.
Team
Starting at $8,000
For cross-functional discovery teams using MolAgents in active workflows.
- Multiple program workspaces
- Full agent roster
- Collaboration & shared threads
- Memory & evidence tracking
- Admin controls & priority support
Enterprise
Custom
For larger biotech and pharma organizations with security, deployment, and governance requirements.
- Unlimited or custom deployment scope
- SSO & governance controls
- Private deployment & VPC options
- Custom integrations & audit logs
- Dedicated support & SLA
Bring One Real Decision Into MolAgents
Start with a live molecule question and see how discussion changes when every specialist viewpoint is explicit.